Breaking News Instant updates and real-time market news.

SPNS

Sapiens

$10.67

0.29 (2.79%)

07:47
08/07/18
08/07
07:47
08/07/18
07:47

Sapiens raises FY18 adj. operating margin view to 13.0%-13.2% from 12%-13%

  • 07

    Aug

  • 13

    Aug

  • 14

    Aug

  • 15

    Aug

  • 16

    Aug

  • 16

    Aug

SPNS Sapiens
$10.67

0.29 (2.79%)

09/06/17
COWN
09/06/17
INITIATION
Target $14
COWN
Outperform
Sapiens initiated with an Outperform at Cowen
Cowen analyst Avishai Kantor initiated Sapiens with an Outperform rating as he sees meaningful upside driven by earnings growth and a recovery in its multiple. He noted the shares have been under pressure since the large acquisition of a competitor and he sees the weakness as a buying opportunity. Kantor has a $14 price target on Sapiens shares.
02/16/18
LEHM
02/16/18
DOWNGRADE
Target $11
LEHM
Equal Weight
Sapiens downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Tavy Rosner downgraded Sapiens to Equal Weight and lowered his price target for the shares to $11 from $17. The analyst sees a lack of near-term catalysts given the company's e "muted" growth profile. He does not expect shares to rerate in the near term with Sapiens' 2018 guidance for revenue growth in the range of 3%-4%.
05/08/18
WBLR
05/08/18
DOWNGRADE
WBLR
Market Perform
Sapiens downgraded to Market Perform from Outperform at William Blair
William Blair analyst Justin Furby downgraded Sapiens to Market Perform saying consensus estimates for 2019 could be a "too aggressive." The analyst is taking a more cautious stance following the company's Q1 results.
05/08/18
05/08/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Comcast (CMCSA) downgraded to Neutral from Overweight at Atlantic Equities. 2. Zillow (Z, ZG) downgraded to Sector Perform from Outperform at RBC Capital with analyst Mark Mahaney citing the recent stock price appreciation. 3. XL Group (XL) downgraded to Sector Perform from Outperform at RBC Capital with analyst Mark Dwelle saying the company's first quarter earnings did not contain any red flags around the sale of the company to AXA (AXAHY), which is on track to close in late second quarter or in the third quarter. 4. Ionis Pharmaceuticals (IONS) downgraded to In Line from Outperform at Evercore ISI with analyst Josh Schimmer citing the safety concerns around volanesorsen discussed in the latest FDA briefing documents, which also "dismantled the company's claims" that the treatment leads to benefits in pancreatis. 5. Sapiens (SPNS) downgraded to Market Perform from Outperform at William Blair with analyst Justin Furby saying consensus estimates for 2019 could be a "too aggressive." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.